Who Paid My Doc
Study to Evaluate the Safety, Tolerability and Efficacy of Bf-200 Ala (Ameluz) in the Field-Directed Treatment of Actinic Keratosis (Ak) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using A Rhodoled Lamp
ClinicalTrials.gov NCT05662202
Research payments
$505,819
Through program year 2025, $505,819 in research payments was reported against Study to Evaluate the Safety, Tolerability and Efficacy of Bf-200 Ala (Ameluz) in the Field-Directed Treatment of Actinic Keratosis (Ak) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using A Rhodoled Lamp, across 53 payments, paid by Biofrontera Inc..
- Paid by
- Biofrontera Inc.
- ClinicalTrials.gov
- NCT05662202
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $505,819 | 53 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ira Thorla Baton Rouge, LA Named on 18 payments
- Scott Guenthner Greenwood, IN Named on 11 payments
- Edward Lain Austin, TX Named on 6 payments
- John Tu Rochester, NY Named on 4 payments
- Sadra Jazayeri Phoenix, AZ Named on 4 payments
- Nathalie Zeitouni Phoenix, AZ Named on 3 payments
- Todd Schlesinger Charleston, SC Named on 2 payments
- Sherrif Ibrahim Victor, NY Named on 2 payments
- Joel Cohen Greenwood Village, CO Named on 1 payment
- John Strasswimmer Delray Beach, FL Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.